Skip to search formSkip to main contentSkip to account menu

CDK inhibitor AT7519M

Known as: CDKI AT7519, Cyclin-Dependent Kinase Inhibitor AT7519M 
An orally bioavailable small molecule with potential antineoplastic activity. AT7519M selectively binds to and inhibits cyclin dependent kinases… 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

AT7519
Cyclin-Dependent KinasesNegative Regulation of Cell CyclePositive Regulation of Apoptosis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
B457 AT7519, a Multi-Cyclin Dependent Kinase Inhibitor, Induces Apoptosis in Multiple Myeloma via GSK3B
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)